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Abstract
With the current expanded technical capabilities to perform mass spectrometry-based biomedi-
cal proteomics experiments, an improved focus on the design of experiments is crucial.  As it is
clear that ignoring the importance of a good design leads to an unprecedented rate of false dis-
coveries  which  would  poison  our  results,  more  and  more  tools  are  developed  to  help  re-
searchers designing proteomic experiments. In this review, we apply statistical thinking to go
through the entire proteomics workflow for biomarker discovery and validation and relate the
considerations that should be made at the level of hypothesis building, technology selection, ex-
perimental design and the optimization of the experimental parameters.
1. INTRODUCTION
Since the introduction of ‘omics’ technologies in biomedical research, a profound change in
addressing biomedical research questions has taken place as they might often be preferred
over traditional biochemical procedures. As these omics platforms gained popularity with the
development of high-throughput measurement methodologies, they can now be seen as central
players in scientific research. With mass spectrometry-based proteomics as one of the most
mature omics platforms, major advances in the biomedical field have already been achieved.
However,  despite  the  recent  developments  in  the  field  of  both  mass  spectrometry  and
bioinformatics  which  led  to  advanced  sensitivity  and  specificity  combined  with  increased
throughput, the translation of results from biomedical projects to clinical practice remains poor. It
is  therefore  clear  that  the  general  trend  where  initially  promising  findings  do  not  result  in
improvements in healthcare needs to be halted and that a major focus on both the quality and
the design of experiments is mandatory for every new research question. The importance of
experimental design however is not new. Over eighty years ago, Ronald A. Fisher raised the bar
on the quality of  empirical  science when he published the eponymous book  The Design of
Experiments [1]. Today, these ideas remain as relevant as ever. Our vastly expanded technical
capabilities to perform experiments have made it more, not less important to heed the principle
that experimentation requires premeditation. If ignored, we would poison our knowledge by an
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unprecedented rate of false discoveries (type I errors) or needlessly slow down our acquisition
of new knowledge (through type II errors or wasted experimental resources).
A publication in The Lancet by Petricoin et al. still remains one of the best examples to indicate
that,  when experimental  design and subsequent  analysis of  the results is  lacking,  a cancer
diagnostic assay based on SELDI-TOF experiments can be invalidated [2]. Indeed, although the
publication  suggested  that  a  near  perfect  sensitivity  and  specificity  could  be  achieved  to
diagnose ovarian cancer (even at an early stage) in serum samples, other groups indicated the
presence of confounding factors and lack of reproducibility in both the initial dataset and two
related experiments published by the same research group [3,4].  Among the likely culprits were
selecting peaks predominantly at low m/z (where the noise from saturation, miscalibration, and
matrix  molecules  was  the highest),  inconsistent  baseline  correction,  invalidated changes  in
equipment  and  protocol,  miscalibration  of  time-of-flight  to  m/z  conversion,  possible  lack  of
blinding, lack of randomization, no analysis of variation, and no replication over different values
for  important  variables  that  cannot  be controlled.  This  finding  of  severe  deficiencies  in  the
experimental design received a reply from the authors of the flawed study,  which was itself
subsequently thoroughly rebutted [5] . Since then, several other publications have illustrated the
importance of experimental design and the consequences of ignoring the issues that must be
addressed in order to perform successful proteomic studies [6].
In the design of experiments, at least when non-deterministic processes are considered as in
biology and mass spectrometry, statistics plays a crucial role. A first step is to understand what
the inputs and outputs to the process are, what their range is, and what input parameters one
can control — the control variables. Second, in order to be able to perform a sound statistical
analysis after the experimentation is done, it is important to first understand the process that has
generated the data to falsify the research hypothesis. In particular, one should analyze which
assumptions can and cannot be made with respect to the independence of variables, and what
the distributions are from which the observations are  drawn.  The instrument’s  maintenance
status [7], instrument settings, the ambient temperature, and the perfume of choice of the lab
technician can all influence the results. Some of those variables may affect the results more
strongly when a particular combination of multiple variables occurs — an effect that requires
many more sample runs if we wish to be able to discover it rather than the simple main effects
of single variables.
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In a longitudinal study (multiple measurements over time) or case-control study (comparison
between two populations or treatment groups), all the measurements should be generated by
exactly  the  same  protocol.  Apart  from  the  variables  that  were  allowed  to  vary  (i.e.,  time,
treatment,  disease  status),  all  other  parameters  need  to  be  controlled  such  that  the
measurement can be assumed to originate from the same process. Even though such basic
statistical  issues seem straightforward, there are a surprising number of studies that do not
apply them rigorously. Even worse, it is not always feasible to create the ideal experiments due
to various constraints, in which case approximations are needed, which might require custom
analyzing and reporting. For example, decaying instrument performance, batch effects, or time
effects are often difficult to control and should be dealt with by randomization schemes. In this
manuscript  we  apply  statistical  thinking  to  go  through  the  entire  proteomics  workflow  for
biomarker discovery and validation and relate the considerations that should be made at the
level of hypothesis building, technology selection, experimental design and the optimization of
the experimental parameters. An overview of all these steps in the proteomics workflow is also
depicted in Figure 1.
A topic that will not be tackled in this review are the strategies to analyze the vast amounts of
mass spectral data. The appropriate data analysis strategy is often dictated by the type of mass
spectrometry experiment, the objectives of the study and the organism that is scrutinized. For
example, data that originates from selected reaction monitoring requires a completely different
approach than data from shotgun proteomics. 
Most bioinformatics tools for mass spectrometry can be categorized in two classes. A first class
of tools deals with identification of the biomolecules from the full scan and fragment ion spectra.
The second class deals with the quantitative information and summarization towards the level of
the protein, peptide or metabolite. Of course advances in one class like, e.g.,  de novo search
algorithms or algorithms that are invariant for post-translational modification, will influence how
the  second  class  of  tools  will  incorporate  new  information  in  their  quantitative  analysis.
Moreover, it seems that the protein inference problem [8] can be  regarded as a special case of
the  protein  quantification  problem  [9].  Bioinformatics  tools  for  mass  spectrometry  data  are
continuously improved  [10,11,12] and concepts are lively debated by the scientific community
[13]. 
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2. RESEARCH QUESTION AND THE FORMAL HYPOTHESIS
The goal of designing an experiment is to obtain precise and accurate information to answer a
specific research question in a most optimal and unbiased way. Hence, the first step in planning
an  experiment  is  to  formulate  the  scientific  question  to  be  answered.  For  example,  an
experiment  can be exploratory in  nature in  a  qualitative or  quantitative fashion,  e.g.,  which
proteins are present in the sample, or which proteins are expressed differently when comparing
the protein profile of two groups of patients. These high-throughput discovery studies are often
used to generate new lists of hypothetical biomarkers for diagnostics, prognosis or predictive
medicine.  Other research questions may need a more targeted approach as is the case in
verification studies to evaluate potential biomarkers or quantify the presence of a compound in a
particular matrix. Hence, these targeted measurements aim to quantify or detect the presence of
a protein without comparing the observations with a reference measurement, as is the case in
the discovery approach. Moreover, discovery experiments are optimized to identify and quantify
the largest possible number of biomolecules from a single sample. To accomplish this objective,
the  requirements  of  speed  and  reproducibility  are  often  tempered.  By  contrast,  targeted
experiments are conceived to measure only a few biomolecules, but in a robust, reproducible,
and fast manner. Therefore, in discovery experiments the number of proteins that are measured
(P),  is  usually  much  larger  than  the  number  of  samples  (N),  i.e.,  P>>N.  For  targeted
measurements, we have the opposite, P<<N.
Once a research question is settled upon, it needs to be formalized into a proper hypothesis.
Like most analytical techniques, mass spectrometry-based proteomics is affected by noise and
variability. Therefore, statistics is needed to evaluate the meaning of a certain measurement and
whether it is significantly larger or smaller than another measure or fixed threshold value. As
such,  false conclusions from the data or  so called chance findings can be controlled when
thorough  understanding  of  the  noise  source  and  their  statistical  properties  is  present.
Consequently,  it  is  good  practice  to  formalize  your  research  questions  into  a  falsifiable
hypothesis.  The research question from the previous paragraph can be framed in a simple
hypothesis that examines whether there is a relationship between two variables (e.g., protein
expression and treatment effect). This hypothesis can be seen as comparative in nature as it
aims at evaluating the difference between protein expression from two treatment groups, or
evaluate whether a protein abundance is larger than a pre-specified threshold value.
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The simplest  comparative  designs attempt  to gather  sufficient  evidence to support  a  single
hypothesis H1. Collecting evidence to directly support a hypothesis has long been recognized as
unscientific,  as  history  has  shown that  there  is  no  shortage  of  false  hypotheses  for  which
copious amounts of supporting evidence can be produced one way or another. The safe way to
give  credence  to  a  hypothesis  is  to  disprove  its  alternative,  which  Fisher  called  the  null
hypothesis, H0. There are two ways a comparative experiment for verifying a single hypothesis
can give false results:  either  H0 is incorrectly rejected, leading one to mistakenly accept the
study hypothesis H1, or one fails to reject H0 even though H1 is true. The former event is a false
positive or type I error, while the latter is a false negative or type II error. The significance level
of  an  experiment  is  the  probability  of  type  I  errors  when  H0 holds,  and  the  power  of  an
experiment is the probability of avoiding a type II error when H1 holds. While it is trivial to reduce
either probability by choosing a priori  a corresponding significance level at which to reject the
null hypothesis, a careful experimental design isn’t enough to avoid both types of error: one also
needs to run a sufficient number of replicates to understand sources of variation in the data,
both from biological and from technological sources. It is evident that these noise sources will
influence  the  shape  of  the  null  distribution  and  consequently  will  impact  the  choice  of  the
statistical  test  and  its  outcome.  Insight  into  the  technological  and  biological  variability  can
moreover be used to perform  a priori power calculations that yield the minimal sample size
required  to  reject  the  null  hypothesis  with  enough  “power”  when  a  difference  in  protein
expression is present (BOX 1).
A rule of thumb is to keep the hypothesis simple when the technology and experimentation to
falsify the hypothesis become more complex. On the other hand, many scientists want to get the
most  out  of  their  expensive  proteomics  experiments  and  often  combine  multiple  research
questions in one experiment. For example, to test the effect of an antibiotic on multiple strains of
an organism with regards to protein expression over different time points, whilst focusing on
different  matrices  that  require  different  sample  preparation  protocols  (e.g.,  cytosolic,  and
membrane proteins). Data from complex experiments are more difficult to evaluate with simple
statistics such as Student’s t-test, F-test, Wilcoxon signed rank test, or Mann-Whitney U test.
Instead, these complex experiments require more advanced statistical models such as ANOVA,
mixed models,  or  regression models.  In  these statistical  models each question enters as a
factor and it is important to carefully design such experiments in order to avoid nested factors.
Nesting can be avoided by crossing the factors such that every category of one variable co-
occurs in the design with every category of the other variables. In other words, each level of the
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factor has a fundamental property that is the same for every level of the other factors in the
experiment [14]. Furthermore, crossed experimental designs can test for interactions. In nested
designs,  some factors  cannot  participate  at  all  levels  and  studying  interactions  is  thus  not
possible. However, in some occasions it is not possible to guarantee fully crossed experimental
designs, which has an implication on the choice of statistical model to study the nested data.
After formulating a biological question and translating it into a falsifiable hypothesis, the task is
to select  the optimal  technology and experimental  technique to answer  it  [15].  For  a given
biomedical  question,  one  should  identify  the  challenges  involved  and  which  proteomic
approaches are able to address these. Indeed, a variety of proteomic techniques are available
that  all  differ  in  their  versatility,  difficulty  and  overall  costs:  from  global  protein  expression
profiling studies to very focused approaches that measure only pre-specified targets [15].
3. SELECTION OF TECHNOLOGY
Out of all available techniques and instruments, we will focus the rest of this review on protein
discovery and targeted protein identification with LC-(MS)n. Both techniques start from digested,
potentially  labeled,  protein  samples.  While  a  reproducible  sample  preparation  is  essential,
optimal  protein  extraction  from  different  samples  is  still  approached  purely  empirical
[16,17,18,19] and few computational resources exist to improve this step.
3.1 Considerations at the wet-lab level
3.1.1 Digestion
In  peptide-centric  proteomics  approaches  the  proteolysis  of  proteins  into  MS-detectable
peptides is a crucial factor to achieve decent protein and proteome coverage. However, in many
cases protein sequence coverage is low, with some proteins identified by only a single peptide
sequence. In a typical experiment, trypsin is used as protease and cleaves at the C-terminus of
lysine and arginine, producing ‘predictable’ peptides of practical length and favorable charge
which  are  well  suited  for  fragmentation  by  collision-induced  dissociation  (CID)  [20].  Of  the
theoretically possible tryptic peptides, the ones that are typically identified are from 7 to 35
amino acids long, and carry at least a positive charge at each terminus, yielding mostly doubly
or triply charged peptides. However, the use of a single protease will often not suffice to provide
full sequence coverage, and the use of alternative proteases can therefore expand coverage
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[21].  As  a  result,  orthogonal  digestion  is  increasingly  popular,  with  endoproteinase  Lys-C,
cleaving at  the C-terminus of  lysine,  and chymotrypsin,  which cleaves at  the C-terminus of
phenylalanine, tyrosine, tryptophan, and leucine as the most popular alternative proteases. Due
to a less predictable ionization and fragmentation pattern, the peptides obtained from these
proteases can be more difficult to identify. Specific cases where orthogonal digestion has proven
to be beneficial are the study of post-translational modifications, of highly folded proteins, and of
splice variants [22]. In extreme cases, even more than two proteases can be used, as shown by
Swaney et al, where a S.Cerevisiae proteome digestion by five proteases (Trypsin, Lys-C, Arg-
C, Glu-C and Asp-N), led to a doubling of the sequence coverage [23]. A comparative table of
theoretical whole-proteome coverage for  Homo sapiens based on various parallel enzymatic
digests can moreover be found in Vandermarliere et al. [20].
3.1.2 Fractionation
The most common problem in proteomics is that biological samples are too complex to result in
discernible features after LC and MS separation. Because of this, prefractionation of samples is
beneficial if sufficient material is available, though there have been attempts to analyze samples
without  pre-fractionation  [24,25].  A  large  variety  of  fractionation  methods  exist,  including
multidimensional  chromatographic  separations  (e.g.,  reversed  phase,  ion  exchange,  size
exclusion,  and hydrophobic  interactions)  which  generate  separate  fractions,  SDS gel-based
fractionations or those that selectively obtain a particular subset of proteins or peptides (e.g.
affinity-based beads)  [26]. With this wide variety of different fractionation strategies, choosing
the optimal methods might be difficult. Indeed, as not all methods are equally suitable for the
samples of choice, a good consideration of the fractionation methods remains crucial [27]. Even
more important, if a preferred prefractionation method is performed, in a comparative biomedical
study it must similarly be performed for all samples. Additionally, it should be mentioned that
fractionation will introduce additional variability in the sample, which makes good reproducibility
and  minimal  instrument  drift  crucial,  especially  when  performing  quantitative  experiments.
However, this induced variability can be accounted for by an experimental design that employs
isotope label for the relative quantitation of proteins and peptides, e.g., isobaric labels. Doing so,
samples are pooled and fractionated simultaneously such that all  the obtained fractions are
affected  by  the  same  technical  variability,  making  them directly  comparable  in  a  statistical
analysis.
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3.1.3 Co-purification: Pull-down / depletion / enrichment
For several research questions it might be necessary to perform a depletion or a pull-down of a
certain subtype or class of proteins [28]. A wide variety of strategies exist, and depend on the
biomedical tissue or protein class of interest. One of the most typical examples are biomedical
projects where (human) serum/plasma samples are frequently used to deplete highly abundant
proteins  in  order  to  decrease  the  dynamic  range  and  thus  to  increase  coverage  of  lower
abundant proteins. Several different tools exist to achieve the depletion of most of the highly
abundant  proteins,  including Multiple Affinity Removal System (MARS) and ProteoPrep  [29].
Alternatively,  other  techniques which aim to  limit  the extent  of  the  dynamic  range in  blood
samples by enriching the proteins of low abundance, e.g., ProteoMiner beads, can be used as
well.  However, it is important to note that, although empty beads are of regularly use in Western
analysis, empty beads are of limited use in proteomics as they should not be used to quantify
unspecific binding as the bound protein population is always vastly different from the actual
pulldown sample. Some other research questions however, require the pull-down of specific
proteins or a special class of proteins. For example, when a strong focus is present on plasma
membrane proteins, the acute slice biotinylation assay (ASBA) technique can be used [30]. In
designing these kind of experiments, it is crucial to keep in mind that expression profiles from
extreme  experimental  conditions  (e.g.,  controls  are  pull-downs,  cases  are  not)  should  be
avoided, especially since depletion or enrichment tends to be transitive  [31]. Additionally, one
should also  take into account  that  many of  these depletion  technologies  will  also eliminate
associated  proteins  (such  as  albumin  binding  proteins,  antibody  bound  antigens,  etc).
Furthermore,  one  should  be  aware  of  the  implicit  assumptions  made  by  the  normalization
method used, as these often do not hold for co-purification experiments.
3.2 Considerations on the type of experiment
LC-MS-based  experiments  can  roughly  be  divided  into  two  subcategories:  discovery
(untargeted) MS, and targeted MS. The first type of experiments are more comparative, while
the second type of experiments are more quantitative. The major principles behind these two
LC-MS-based categories in proteomics approaches are summarized in  [32,33,34,35]. As the
name implies, protein discovery experiments aim to identify as many proteins as possible in a
sample of unknown content. In these workflows, protein samples are digested into peptides and
fractionation  of  the  resulting  peptide  mixture  takes  place  before  it  is  subjected  to  mass
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spectrometric  analysis.  Despite  the  ability  to  identify  and  quantify  thousands  of  proteins  in
complex samples  [18,36], it still  remains extremely difficult and time-consuming to reveal the
composition of a complete, complex proteome.
For discovery based methods, an important methodological decision that has to be made is
whether the MS acquisition will  be performed in a data-dependent or data-independent way.
Measuring  in  data-dependent  acquisition  (DDA)  mode,  where  precursor  ions  are  selected
automatically from those detected in a survey scan immediately preceding the ion selection, can
result  in  incomplete  sampling  of  complex  peptide  mixtures.  Indeed,  in  DDA the  number  of
peptides that are sampled within one LC-MS/MS run is limited by the local sample complexity
and  concurrent  MS/MS  speed.  This  is  detrimental  for  low  abundant  peptides  in  complex
samples as a single MS spectrum might contain over 100 molecular entities, of which only a
handful can be selected for fragmentation before the next full scan [37]. As a result of this bias
towards  peptides  that  yield  high  intensity  signals,  reproducible  quantification  of  more
stochastically sampled low abundance peptides remains challenging. 
Strategies  which do not  require  the detection  and/or  knowledge of  the  precursor  to  trigger
acquisition  of  fragment  ion  spectra  are  categorized  as  data  independent  acquisition  (DIA)
experiments. In data-independent acquisition, all peptides present in a defined mass-to-charge
window (known  as  a  bin),  are  subjected  to  simultaneous  fragmentation.  As  such  the  link
between precursor and fragment ions is lost which complicates the analysis of the resulting data
sets, and scan performance can be directly impacted by the isolation window width. Therefore
DIA technology depends on a trade-off between the number of bins and the bin width, and even
more  crucially,  on  sophisticated,  tailor-made  bioinformatics  for  the  identification  and
quantification  of  the  peptides.  This  reliance  of  DIA approaches  on dedicated bioinformatics
solutions is due to the wide isolation window (usually >10Da) that intentionally leads to the co-
isolation and co-fragmentation of multiple peptides, which in turn results in much more complex
fragmentation spectra. On the other hand, smart strategies like multiplexed DIA [38] exist that
combine a high scan performance with narrow isolation windows. However, demutliplexing of
the obtained data require even more advance bioinformatics methods.  A special type of DIA is
the SWATH-MS methodology trademarked by SCIEX that provide high resolution fragment ion
spectra of all  precursors in a user-defined precursor ion window  [39]. In SWATH-MS, a DIA
acquisition method is combined with targeted data analysis. Typically, precursor ions from bins
of 25 m/z units are fragmented, recorded with a time-of-flight mass analyzer and extracted ion
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chromatograms of peptides of interest are generated [40]. The method thus allows to quantify
as many components as identified with typical DDA experiments, but with the accuracy of SRM.
Quantitative DDA proteomics experiments can be performed using either relative or absolute
quantification  [41]. Although label-free shotgun experiments are mostly applied when peptide
expression levels in a large cohort of samples need to be compared on a relative scale, the
multiplexing capability of the labeled workflow is often preferred when limited sample material is
available  and  sample  preparation  is  costly.  These ‘multiplexing labeling  procedures’ offer  a
broad variety of approaches to choose from, such as tandem mass tags (TMT)  [42], isobaric
tags for relative and absolute quantification (iTRAQ) [43], and stable isotope labeling with amino
acids in cell culture (SILAC) [44]. Absolute quantification is typically carried out based on relative
quantification  of  sample  peptides  against  spiked-in  synthetic  peptides  labeled  with  heavy
isotopes. Approaches for shotgun proteomics experiments include the absolute quantification
(AQUA)  [45] strategy or  QconQAT  [46].  To select  proper  peptide  candidates,  computational
packages can filter an in silico digest of the protein of interest for those peptides that are unique
across the organism, detectable with MS, and preferably likely to remain unmodified. Of course,
it is also important to take note of the limitations of these various techniques when selecting the
most suitable DDA approach for the study at hand  [47]. For example, although multiplexing
strategies  have  many  advantages,  it  remains  important  to  fully  understand  the  ratio
compression due to co-isolated and co-fragmented ions and the consequences it has on the
obtained data [48,49].
In contrast to discovery experiments, targeted proteomics experiments are based on an a priori
defined set of proteins of interest. This set can be determined from prior biological knowledge or
from previous discovery experiments. The sample processing protocol is essentially identical to
that of discovery approaches, in that  proteins are first  digested to peptides,  which are then
separated with liquid chromatography and analyzed with MS. The major difference is found
within the mass spectrometer, where peptides of interest are now targeted for fragmentation,
followed by quantitative detection of one or more of the resulting fragments. This enables the
isolation (or can even disprove the presence) of one or more proteins of interest in a sample
with very high specificity and sensitivity [50]. The combination of a precursor mass and one of
its fragment ion masses is referred to as a transition. Two different targeted approaches exist:
selected reaction monitoring (SRM; sometimes also referred to as multiple reaction monitoring
or  MRM),  and parallel  reaction monitoring (PRM).  In  SRM, only a subset  of  transitions are
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typically monitored. This way, SRM experiments filter out background signals, which increases
the signal-to-noise ratio and thus achieves a more accurate quantification when compared to
untargeted  experiments  [51].  Although  SRM  measurements  are  still  the  gold  standard  for
targeted analyses, the development of high resolution/accurate mass (HR/AM) instruments is
revolutionizing  the  field  and  has  enabled  the  development  of  the  PRM  technique  as  an
alternative targeted approach  [33]. PRM differs from SRM in that it monitors multiple MS/MS
fragmentation channels simultaneously,  which not  only allows more precise quantification of
peptides,  but  also  enables further  improved detection  limits.  PRM relies on highly  accurate
mass measurements of both precursor and fragment ions, which allows for a narrow precursor
ion selection window. 
3.3 Considerations on the technology
A  technology  choice  also  implicitly  enforces  method-related  constraints  that  need  to  be
considered, as these parameters cannot change and might limit the scope of the experiment.
These parameters are found for both the LC as well as the MS technologies.
3.3.1 Mass spectrometry
3.3.1.1 Mass accuracy
Generally defined as the measured mass minus calculated mass in parts per million (ppm),
mass accuracy is a crucial parameter to take into account when answering certain biomedical
research questions. Not only will  it  influence the false discovery rate of protein and peptide
identification, as a molecular mass of a peptide determined with 1 ppm mass accuracy rules out
about 99% of amino acid compositions possible for a given integer or nominal mass [52], it also
influences the ability to distinguish isotopic patterns. This is important in peptide intensity- based
quantification and in charge state determination.
3.3.1.2 Mass resolution and mass resolving power
The  mass  resolution  of  an  MS  instrument  influences  whether  a  mass  spectrometer  can
unambiguously determine the elemental composition for confirmation of empirical formulas or
identification of unknowns. The better the mass resolution, the less likely it is that a mass peak
of  interest  will  be  merged  with  an  interfering  ion  from  the  sample  or  background.  Mass
resolution can thus be defined as the minimal mass difference between two spectral  peaks
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which  can  be  clearly  distinguished.  Measuring  with  higher  mass  resolution  requires  more
measuring  time,  and  a  trade-off  between  resolution  and  time  should  therefore  be  made.
Typically, high resolving power can be found in orbitrap instruments (100.000-240.000 Full width
at half maximum (FWHM) at a given m/z), followed by time-of-flight instruments (10.000-60.000
FWHM at a given m/z), while quadrupoles and especially ion traps have lower mass resolutions
(1.000-20.000 FWHM at a given m/z).
3.3.1.3 Scan duty cycle
Duty cycles are most often defined as the proportion of time during which a system is operated;
for mass spectrometers, the typical meaning of duty cycle refers to the amount of time spent on
an MS or MS/MS scan. It  is important to consider how to use this scan time optimally: how
many MS/MS spectra per full MS do you want to obtain, what target resolution do you want to
achieve in the MS1 and MS2 levels, and do you want different fragmentation times? Because of
the trade-off between resolution in MS1 and the number of identifications in MS2, optimization
of the duty cycle needs to be carefully considered in light of the experiment at hand.
3.3.1.4 Dynamic exclusion
Most  data-dependent  or  targeted  selected  ion  monitoring  (SIM)  measurements  employ  the
dynamic exclusion feature, in which a mass is excluded over a defined period of time (typically
ranging from 15 – 600 s) after it is analyzed. This provides the instrument with a better chance
to analyze less abundant ions that  are eluting at  the same time as the more dominant but
excluded  ions.  Indeed,  implementing  dynamic  exclusion  is  very  beneficial  for  biomedical
samples as the complexity of these samples can easily overwhelm the separation efficiency of
LC  instruments.  Without  dynamic  exclusion,  highly  abundant  peptides  will  be  repeatedly
selected for fragmentation in data-dependent measurements, at the cost of overall proteome
coverage  [53].  However,  in low complex samples,  it  might  be beneficial  to disable dynamic
exclusion  such  that  multiple  scans from a data  dependent  acquisition  can be employed to
increase  spectrum  quality  by  selecting  the  fragment  spectrum  at  the  apex  of  the
chromatographic  profile  such  that  ion  abundance  is  most  optimal  for  fragmentation.
Alternatively, multiple fragment spectra corresponding to the same chromatographic profile can
be merged to improve spectral quality. 
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3.3.1.5 Mass range / mass window
Another factor that should be taken into account is the required mass range. The mass range is
the  range  of  m/z’s  over  which  a  mass  analyzer  can  operate  to  record  a  mass  spectrum.
Depending on the type of molecules (e.g., lipids or proteins) different windows are needed, as
different  mass  ranges  are  required  to  obtain  a  sufficiently  broad  overview.  In  addition,
depending on the type of mass spectrum (e.g. full spectrum, fragmentation spectrum), different
settings are applied. The width of mass isolation windows used for precursor ion selection is
another crucial factor that needs to be determined. Mass windows that are too small (e.g., 1
m/z) lose essential information about isotopes, while setting up too large a window can lead to
the inclusion of co-eluting molecules. Additionally, the type of instrument is also a crucial factor
in deciding the width of the mass window or the instrument resolution, as in quadrupoles for
example, setting a mass window too narrow will  result in lower transmission and thus lower
sensitivity and spectral quality.
3.3.1.6 Spectral accuracy
In  some  experiments,  the  isotope  pattern  can  be  of  interest.  In  these  cases,  the  spectral
accuracy, which indicates the similarity between a measured spectrum (and thus the isotope
patterns) and its theoretical spectrum, are of major importance. Furthermore, some software
relies on spectral information, such as the relative peak heights in isotope clusters, to aid in the
identification  of  the  biomolecule.  A user  of  such  software  should  be  aware  of  the  spectral
accuracy  of  the  employed  instrument  because  several  types  of  error  can  compromise  the
relative peak intensities and corrupt (i.e., add uncertainty to) the molecular identification. 
3.3.2 Liquid Chromatography 
Mass  spectrometry  is  the  central  technology  in  proteomics  and  is  used  for  detection  and
identification of thousands of proteins and peptides in a single experiment. However, in order to
deal with the high complexity of typical proteomics samples, hyphenated techniques must be
used to increase separation power (peak capacity), selectivity, the measured dynamic range,
detection sensitivity and sample throughput. In short; a single peak in the mass spectrometer
should  correspond  to  a  single  peptide  and  should  be  detected  sensitive  enough.  This  is
especially true for quantitative analysis in which case interference with other peptides in the
analysis needs to be avoided as much as possible.  Liquid chromatography is the preferred
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hyphenated tool in proteomics research as it  provides high-speed,  high-resolution and high-
sensitivity separation of macromolecules. In chromatography a number of parameters have a
big influence on reproducibility and should therefore be controlled.
1) Flowrate and gradient mixing:
Over the years, many different techniques have been developed to increase peak capacity and
sensitivity in LCMS and applied to proteomics.  The most successful LC technique in proteomics
is without any doubt the application of miniaturized (nano) chromatography in which very low
flows  are  used  (few 100nl/min)  on  very  narrow columns  [54].  However,  although  nano-LC
greatly improves sensitivity of the analysis, it requires miniaturization of pumps, controllers and
plumbing  in  the  HPLC  which  has  detrimental  effect  on  reproducibility.  Furthermore
miniaturization  of  the  LC  system  also  influences  the  accuracy  of  several  important  LC
characteristics including control  of  flowrate,  solvent  mixing and gradient  formation.   For this
reason,  often higher flowrates are chosen for  targeted proteomic applications in  which high
reproducibility is required  [55].  In addition higher flowrates have the advantage that ultrafast
gradients  (UPLC)  can be used  increasing  sample  throughput.  Higher  reproducibility  is  also
achieved when splitter-free HPLC systems are used.
2) Temperature:
Column temperature plays an important role in controlling peak spacing in reversed-phase liquid
chromatography separations and temperature has a big influence on retention time. Excellent
temperature stability can lead to a high degree of reproducibility, therefore a form of temperature
control is essential if one wants to obtain good reproducibility. Indeed, fluctuations in column
temperature can give rise to peak retention times drifts, changes in viscosity of mobile phases
and overall  changes in   LC pressures.  These changes can have tremendous effects  when
comparing multiple LC-MS experiments,  in  particular  in  label-free experiments,  where these
changes create biases and difficulties to perform chromatographic alignment of peptide elution
peaks [56,57].
3) Back pressure:
Column back pressure is evidently linked directly with flow rate and solvent composition which
need to be controlled precisely.  However, column back pressure is influenced greatly by column
temperature.  When  temperature  increases,  the  column  back  pressure  decreases,  as  the
temperature decreases, the back pressure increases. This property is useful when working with
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columns with small particles (<2 µm) such as those used in UPLC or probably more relevant for
proteomics, the use of long (nano-HPLC) columns in which case good temperature control is
essential [58]. 
4. EXPERIMENTAL DESIGN
4.1 Observational studies
In  the  biomedical  field,  the  vast  majority  of  variables  cannot  be  freely  controlled  but  are
conditioned on the individuals included in the study. It is not possible to set variables at the
biomolecular level independently to arbitrary levels as the experiment designer is constrained to
merely selecting subjects and sometimes their treatment. 
In proteomics studies, most observational research methods are based on a cohort study or a
case-control  study.  Cohort  studies  can  be  defined  as  studying  a  group  of  people  with
predetermined characteristics who are followed up over a period of time to determine incidence
of or mortality from some specific diseases. Cohort studies can be prospective studies where
sample collection starts before the individual develops the disease, or retrospective when the
samples have been collected in the past for other purposes. Case-control studies, on the other
hand, determine the relative importance of a variable in relation to the presence or absence of a
disease [59]. In general, this type of study will retrospectively compare two (or more) groups.
One group has the disease or outcome of interest, and the other group is constructed to consist
of people closely matching the first group. Case-control studies are thus able to generate a lot of
information from a relatively small group of samples but a decent specification of both the study
group and how to construct a valid control group are required.
4.2 Exploratory experiments
In section [3.2], we distinguished discovery and targeted experiments: in MS, it is customary to
first cast a wide net to discover molecules potentially correlated with the disease, and only in a
later stage measure more carefully a small number of molecules with higher accuracy. If we are
not restricted to an observational study, the same principle holds for finding interesting control
variables  (treatment  parameters).  The  first  step  of  a  study  typically  consists  of  performing
exploratory  experiments,  also  called  screening  experiments.  When  there  is  no  significant
knowledge available on which factors influence a response of  interest,  it  is  conservative to
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consider a high number of factors in a first phase. The Pareto principle, also called the 80-20
rule, is the assumption that only a small subset of these effects account for most of the variation
seen in the response. It is exactly the identification of these few effects which is of interest in
screening experiments. As generally this is only the first step in experimentation, one typically
pays attention to performing this step as economically as possible: usually only main effects are
investigated,  sometimes  in  combination  with  two-factor  interactions,  but  even  these  are
confounded  in  many  screening  designs.  Furthermore,  one  typically  only  employs  two-level
designs  to  minimize  the  required  number  of  samples.  After  identifying  the  most  significant
factors, one can proceed to design an experiment to fit a response surface model. For a more
elaborate discussion on screening experiments, the reader is referred to [60] and [61].
4.3 Building blocks
Once the variability of the biology and the limits enforced by technology are understood, you
can  decide  on an  optimal  design to  reject  the  study’s  hypothesis.  A good overview of  the
principles of  experimental  design in the context  of  MS is given in  [62]  and a more limited
introduction to some of the concepts can be found in [63]. A summary of a typical experimental
process in proteomics is described in  [64]. We will revisit the main principles of experimental
design here very concisely.  The basic tools of experimental design are: controls,  replication,
randomization, blocking, and pooling.
4.3.1 Controls 
Controls are reliable reference signals with which the signal of interest can be compared. In
mass  spectrometry  they  can  take  the  form  of  regular  quality  control  samples  of  known
composition,  or  in  a  comparative  study the samples  of  the  untreated  group.  To achieve  a
flawless  experimental  design,  it  is  essential  that  the  control  samples  undergo  the  same
procedure  as  the  treatment  group  samples  to  the  maximum extent  possible,  otherwise  an
unrecoverable bias may be introduced in the signal.
4.3.2 Replication
Replication is necessary to allow any statistical conclusions. Any signal observed in a proverbial
“sample of one” may or may not come around by chance. Only after observing an effect multiple
times, it is more convincing that a difference in the signal is likely a true, reproducible difference
between  two  groups.  Replication  can  happen  at  different  steps  in  the  mass  spectrometry
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pipeline. Biological replicates are samples from separate individuals, or at least from separate
locations in the same individual. They are processed independently,  but in parallel, over the
whole pipeline. Technical replicates are generated from the same biological sample at some
point  in  the  pipeline.  Biological  replicates  carry  more  information  as  averaging  over  their
measurements allows to cancel out process variation as well as biological variation. Technical
replicates are used because they allow for an estimate of how much of the variation is due to
the  process  alone,  and  because  they  are  cheaper  and  easier  to  create.  However,  in
reproducible  proteomics  platforms,  technical  variability  is  mostly  negligible  compared  to
biological variability and in all  these cases, biological replicates should always be preferred.
When samples are subdivided in multiple batches, it is important to note that these samples
must be performed in parallel and that independent experiments are difficult to compare. 
4.3.3 Randomization
Randomization of the allocation of samples to the available treatment groups and processing
slots prevents systematic bias from process drift and other confounding variables that cannot be
controlled.  Studies  without  random  assignment  are  quasi-experiments.  They  cannot  prove
causalities because the observed effect may as well be caused by a confounding variable. A
well-known confounding variable is changing instrument performance over time. Running the
treatments  groups  unmixed,  one  after  another,  exposes  the  later  groups  to  a  differently
performing instrument than the earlier groups, an effect which may dominate any difference in
properties between the groups. A randomized order of samples will approximately balance out
such differences.
4.3.4 Blocking 
Blocking  is  the  fair  allocation  of  different  values  of  variables  that  can  be  controlled  to  the
samples. It is used to prevent bias from the variables that can be controlled and is superior to
randomization  because  the  allocation  can  be  balanced  between the  sample  groups,  which
reduces  variation  and  allows  for  more  accurate  estimates  of  the  influence  of  the  variable.
Neglect of blocking and randomization can be a fatal flaw in a proteomics experiment, rendering
the acquired data worthless and, worse, tempting the experimenter to draw false conclusions,
leading to embarrassment [65,5]. 
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4.3.5 Pooling 
Pooling is the mixing of multiple samples of the same group as a mean for signal stacking and
cancelling of noise. Pooled designs are attractive because they can minimize the experimental
cost. In some cases, pooling can be necessity to provide sufficient material for experimentation.
Mostly, pooling is done in an effort to reduce the effect of biological variability, since it results in
biological  averaging  for  proteins  and  a  lower  overall  variability.  In  general,  the  variance
reduction due to the pooling of samples should compensate the reduction in sample size such
that the statistical power is maintained. Via statistical theory, optimal pooling designs can be
developed  that  specify  the  number  of  samples  and  experiments  to  obtain  the  statistical
requirements  that  are equivalent  to  a  design that  does not  employ pooling.  Often such an
equivalent design results in a slight increase of the total number of samples. However, pooling
should be used with caution as it makes the interpretation of the outcomes more tenuous. For
example, when concentrations vary exponentially, a single high-dose sample can dominate the
signal  of  its whole pool.  Pooling should therefore only be used when the effects are linear
[66,67,68,69]. Another point of attention are outliers that cannot be detected in pooled designs
and often lead to an underestimation of the protein-specific variance. 
4.4 Design methods
A number of higher level tools have been developed that combine the previous elements in
commonly  used  patterns  for  experimental  design.  We can  distinguish  fixed  strategies  and
flexible strategies. In fixed strategies, the complete experiment is fixed in advance. Advantages
include  the  simplicity  of  the  post-experiment  analysis,  the  prior  knowledge  of  the  relation
between  the  observations  (e.g.,  maximizing  the  independence  of  the  observations,  or  the
spread  over  the  space  of  control  variables),  and  the  possibility  to  assess  in  advance  the
statistical power towards certain hypothesis tests or the accuracy achievable when estimating
the parameters of the model.  Flexible strategies perform experiments in sequence,  deciding
lazily on the next experiment to perform when the previous one is finished or when it is time to
decide on the control variables. Its crucial advantage is that attention can be directed to regions
in  the  control  variable  space  which  are  most  interesting  or  least  understood,  saving
experimental budget (Figure 2).
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4.4.1 Fixed design methods
The standard, classical experimental designs are fixed designs. A widely made assumption in
classical design is that the biological phenomenon under study varies smoothly under moderate
changes of the control variables (factors), so that it is sufficient to consider only a few levels for
each  factor.  The  most  thorough  of  classical  designs  is  the  full  factorial  design,  in  which
experimental runs are executed for all combinations of the factor levels. As the number of runs
in this approach is exponential in the number of experimental factors, it is only feasible for small
design problems. Nonetheless, it has been successfully used, for instance by [70].
To overcome this issue, one can obtain a fractional factorial design by intelligently choosing a
subset of the full  factorial design. However, this comes at a cost as the smaller the chosen
subset,  the  more the main  effects  will  be  confounded with  interaction  effects.  That  is,  it  is
impossible for any subsequent data analysis to disentangle effects caused by particular value
combinations of  two (or  more) factors from effects caused by a single factor  [71] used this
approach to improve proteome coverage on an LTQ-Orbitrap by evaluating the effects of  9
instrument parameters.  Both fractional and full  factorial  designs however have an additional
disadvantage,  since the number of runs needs to be a power of the considered number of
levels.
Plackett-Burman designs are mainly used for screening purposes to estimate main effects as
they are typically  confounded with  the interaction  effects.  They are very economical  as for
instance up to 11 two-level factors can be estimated in a 12-run design. An example can be
found in  [72].
When the goal is to fit a second-order response surface, more apt designs are available, such
as  the  central  composite  design  and  the  Box-Behnken  design.  The  former  starts  from  a
(fractional) factorial design, but it  is augmented by including more levels of the experimental
factors as this allows to estimate curvature of the response.  The latter, by contrast, does not
start from a fractional factorial design, typically allowing for a more efficient estimation of the
effects.
These  classical  design  approaches  can  typically  be  found  in  statistics  handbooks  and  the
designs are easily created, even by hand. The downside is that these approaches are not very
flexible; they only allow certain numbers of runs and in case there are additional constraints they
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cannot be easily used. Adapting the problem to fit these designs often does not lead to good
solutions.
4.4.2 Flexible design methods
Compared to fixed designs, which are normally theory driven, flexible designs allow for more
freedom during the data collection process.  One advantage is that you can direct attention to
regions in the control variable space which are most interesting or least understood. Since the
several observations made are not independent, the analysis of experimental results is more
complex  and  fragile.  Still,  theoretical  guarantees  w.r.t.  the  informativeness  of  the  obtained
measurements can be provided. E.g., a simple and well-studied setting, known as the ‘multi-
armed bandit problem’ [73], considers a situation where there are several discrete options (e.g.,
treatments)  each  producing  a  randomized  output  and  we  want  to  perform  experiments  to
determine  the  option  giving  the  highest  expected  output.  In  this  idealized  situation,  simple
adaptive experiment selection strategies exist that are provably optimal [74]. In general, the use
of flexible experimental strategies to fit  statistical models is investigated in the field of active
(machine)  learning  [75],  while  the  problem of  finding  through  experiments  the  best  control
values to achieve a particular goal is studied in the field of function optimization. Much of the
function optimization literature assumes that function evaluations are inexpensive compared to
the optimization algorithm itself, which is definitely not the case for MS experiments. Fortunately,
since the introduction of Efficient Global Optimization (EGO) by Jones [76] more attention has
gone  towards  optimization  using  as  few  function  evaluations  (sample  runs)  as  possible
[77,78,79,80].  This  is  achieved  by  fitting  a  model  to  the  measurements  made so  far,  and
choosing the next experiment based on the predictions by the model and an ‘infill criterium’. The
model  works  as  a  surrogate  for  real  experiments  during  the  in  silico  selection  of  the  next
experiment.  The  complexity  of  the  model  can  vary  according  to  the  relative  cost  of  the
experiment  and  the  computation.  Gaussian  processes  are  the  typical  choice  if  the  cost  of
executing an experiment dwarfs any computational cost, but faster alternatives are available
[81,82]. Efficient surrogate-based optimization methods assume a continuous design space, but
the  same  methodology  also  works  in  discrete  spaces,  even  in  the  very  high-dimensional
chemical  space  [83].  The statistical  analysis  of  the  measurements  obtained  from a flexible
strategy is far more delicate, as the samples are not independently and identically distributed.
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Depending on the purpose of the experiment being designed, the above tools can be applied in
various ways.  As pointed out,  we can distinguish between explorative experimentation,  and
experiments where we want to answer specific questions.
4.5 Hypothesis tests
Several  strategies  exist  to  determine  what  experiments  to  perform.   Still,  the  choice  for  a
particular  strategy will  depend for  a large extent  on the goals  one wants to reach.   Before
deciding on a strategy to follow, it is important to analyze the models one wants to build and the
hypotheses  one  wants  to  test,  and  hence  the  expected  accuracy  of  these  models  or  the
expected power of these hypothesis tests a proposed strategy may yield. For example, if one
wants to test a collection of hypotheses each comparing two groups, it is important to ensure
that  the selected design will  contain of  each of  the groups compared in  each hypothesis a
sufficiently large number of cases.  
Strategies  where  experiments  are  selected  as  a  function  of  earlier  results,  such  as  active
learning,  may allow to  reduce  the  cost  of  building  a  good  predictive  model  for  a  practical
application.  However, a disadvantage of such methods is that data obtained in this adaptive
way cannot be used easily for hypothesis testing as normally the assumptions underlying such
tests are not satisfied.
4.6 Iterative designs
Sometimes, it is hard to estimate in advance how large a sample size is needed to perform the
analysis.   In such cases, an iterative design may be appropriate.  The main idea is to first
analyze a smaller  sample cohort,  and only if  the result  is  unsatisfactory (e.g.,  the model  is
insufficiently precise or the null hypothesis can't yet be rejected) one next invests in a larger
sample size.
One easy way to do so is to make two satisfactory designs, one of which contains a subset of
the experiments of  the other one.   One can then first  perform the smaller  design and then
reevaluate.
Care needs to be taken when many iterations are performed and evaluated iteratively using
hypothesis  tests.   Some  hypothesis  tests  (e.g.  the  t-test)  are  robust,  i.e.  they  still  yield
21
conservative  p-values  even  if  performed  iteratively  on  a  growing  sample,  but  this  is  not
applicable to all hypothesis tests.
5. OPTIMIZATION OF EXPERIMENTAL PARAMETERS
Once a researcher has settled on the research hypothesis, selected the optimal technology for
falsifying the hypothesis, and designed an experiment to control the confounding factors, the
experimental parameters can be optimized to generate a data set rich of information. Of course
this depends strongly on the selected technology, but a number of models exist that can be
applied in the shotgun or SRM/PRM quantification settings. Within one technique it is possible
to explore the parameter space for  an optimal  experimental  result  [51,84].  While  optimizing
these experimental  parameters, two different approaches are followed for shotgun discovery
experiments versus targeted SRM experiments. Since shotgun experiments are interested in
detecting as many peptides as possible in the samples, it can be referred to as a bulk process in
which parameters are only optimized in a general manner. In targeted analyses, on the other
hand, an optimization process must be performed for each a priori known peptide of interest
separately,  which requires individual optimization of transition-specific parameters in order to
achieve  maximal  signal  and  sensitivity  [85].  Large-scale  SRM  assays,  where  hundreds  of
peptides need to be targeted, require even MS instrument parameters that work well with the
broad  diversity  of  peptides  to  be  targeted.  Software  packages  and  computational  studies
attempt to improve or assist determining these parameters for a given experiment [86]. These
efforts  start  with  modeling  the  proteomics  pipeline  [87] to  optimize  some  experimental
parameters. With the latter application fields in mind, we will describe where improvements to
the experimental setup can be made when using computational tools.
5.1 Protease activity
In peptide-centric LC-MS methods, the digestion of proteins into peptides (i.e. proteolysis) is an
important aspect. Although trypsin can be seen as the standard protease used in most shotgun
and targeted approaches, other proteases can be beneficial in the workflow as well. To optimize
an experiment, it might thus be beneficial to know which proteins will be cleaved by a certain
protease, and in case of a priori known proteins to be measured in targeted experiments, which
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peptides will be cleaved from a certain protein. This information is crucial as only these peptides
will be analyzed via LC-MS and thus can be detected in the experiment.  Predictive proteolysis
models  can  thus  improve  identification  rates  in  shotgun  proteomics  and/or  provide  a  priori
prediction  of  suitable  peptides  for  targeted  proteomics  analyses  [86].  Software  predicting
cleavage  probabilities  exists  for  many  proteases  [86],  with  as  usage  mode  the  theoretical
digestion  of  a  single  protein  or  mixture.  For  trypsin,  for  example,  Cleaving  prediction  with
decision trees (CP-DT) uses the positional information of amino acid sequences around the
tryptic site to estimate whether or not the protein will be cleaved [88]. By ranking the peptides by
the probability  that  they will  occur  after  tryptic  proteolysis,  a  list  of  peptides  which  can be
potentially detected is generated.
5.2 Liquid Chromatography: Retention time prediction
The separation of digested peptides with LC prior to mass spectrometric analysis is one of the
most used separation techniques in proteomics. As the amount of time that a peptide is retained
on a LC column, i.e. the retention time (RT), is independent of the information present in the
MS/MS scan,  LC retention  time  represents  another  parameter  that  can  be  computationally
optimized. In shotgun discovery experiments, prediction of the retention time can be used to
increase  peptide  identification  confidence  [89],  while  for  targeted  applications,  standard
gradients can be customized to make sure the targeted peptides have little overlap with other
peptides.
Although the prediction of peptide LC retention times might struggle with the large variety across
LC methods and analyses, predictive models have been built for chromatography in proteomics,
helping experimentalists by providing expected elution times or hydrophobicity indices (in case
of  reverse phase chromatography)  [86].  While  the  first  RT prediction  models  assumed that
peptide RT is a linear function of the amino acid sequence [90], more recent models also focus
on  peptide  length  or  positional  effects  of  the  amino  acid  residues  [91,92].  Even  more
sophisticated models, including SSRCal, calculate retention time as a weighted sum of retention
coefficients for the individual residues in a peptide and then correct for empirical factors such as
length influence and the tendency to form helical structures [93]. To accommodate for different
experimental  LC conditions Moruz  et al. proposed to derive a retention index for  a specific
condition using data driven regression algorithms [94]. There tool ELUDE is fully portable to new
chromatographic  condition  and works  for  post-translationally  modified peptides as  well  [95].
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Besides computational models, also retention time peptide standards can be added to samples
to normalize peptide retention time across multiple LC-gradient elution profiles [96]. 
5.3 Ionization efficiency/ peptide detectability
The analysis of complex digested samples by LC-MS/MS goes hand in hand with the current
inability  to  detect  all  eluting  digested  peptides  in  one  LC-MS  experiment.  Computational
methods, however, are able to predict the ionization efficiency of a certain peptide and although
detectability  is  the  result  of  poorly  understood  processes  of  getting  the  peptide  in  solution
subsequently ionized and picked up by the ion detector, it is known that the likelihood to detect a
peptide in  a certain proteomics experiment depends on four major factors:  1)  the chemical
properties of the peptide, 2) limitations of the peptide identification protocol, 3) the abundance of
the  peptide  in  the  sample  and  4)  the  presence  of  competing  peptides  in  the  sample.
Kelchtermans  et al. provide an overview of different computational models which predict the
peptide detectability based on these factors [86].
Again,  these  peptide  detectability  predictions  can  be  used  to  address  several  problems in
proteomics experiments. In discovery experiments, peptide detectability can be used to guide
protein inference problems and to help label-free quantification [97]. For targeted experiments,
the prediction of the detectability of proteotypic peptides is very helpful to optimize the SRM
transitions  to  be  detected  in  an  experiment.  Here,  commonly  occurring  highly  detectable
peptides  might  crowd  out  the  peptides  of  interest.  Based  on  prior  knowledge  these  very
abundant  peptides  can  be  identified  and  the  experiment  can  be  set  up  to  minimize  their
interference.  For  example,  the  common  Repository  of  Adventitious  Proteins  (cRAP,
http://www.thegpm.org/crap/) contains a list of contamination proteins that are commonly found
in proteomics experiments. Based on their physicochemical properties, the SRM transitions can
be  optimized  to  avoid  interference  by  peptides  originating  from  these  commonly  occurring
proteins. Of course, this does not have to be limited to only contaminants, but can include other
frequently occurring highly proteotypic peptides that are likely to have a major influence as well.
5.4 Fragmentation modeling
Peptide identification in standard LC-MS/MS-based proteomics experiments typically relies on
the prediction of fragment ions and the quality of the experimentally determined fragmentation
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spectra for database-driven target identification [98]. In an MS/MS spectrum, the intensity of the
peptide  fragment  ions  is  dependent  on  both  the abundance  of  the  peptide  as  well  as  the
efficiency of bond breaking. Although some naïve models make the assumption that all peptide
bonds break with equal probability and that each resulting fragment will  take on all  charges
below that of their precursor ion, experimental spectra are more complicated. Predicting the
fragmentation  patterns  of  a  peptide  and  the  fragment  ion  intensities  is  therefore  of  crucial
importance to understand the patterns behind peptide fragmentation [98]. 
Fragmentation of a peptide bond is either a charge-directed process, which involves a mobile
proton migrating to the bond, or a charge-remote process, which is determined by the delicate
balance between the total number of available protons and the number of proton sequestration
sites (basic amino acids) [98].
Whereas early peptide fragmentation prediction tools such as MassAnalyzer  [99] implement a
deductive physicochemical model of peptide fragmentation based on this knowledge, current
state-of-the-art  prediction tools such as PeptideART  [100] and MS2PIP  [101] employ a fully
data-driven machine learning approach to compute accurate peptide fragmentation models from
the amino acid properties in a peptide. This information can be beneficial both to increase the
protein identification (coverage) in discovery experiments as well as the proteotypicity of the
fragment ions for SRM targeted assays.
For  targeted  SRM experiments,  collision  energies  (CEs)  are  frequently  optimized  for  every
target peptide individually to increase the fragment ion intensities in order to attain the maximum
sensitivity. However, instead of optimizing these CEs empirically for each peptide, predicting the
optimal  CE  value  for  each  target  will  decrease  the  time  required  for  optimizing  the  tune
parameters and tries  to find  this  CE which is  optimal  for  a  broad range of  peptides  to  be
measured in the SRM assay [102].
5.5 Charge prediction
With electrospray ionization (ESI) – based LC-MS/MS, the same peptide can be ionized with
different  charge  states.  As  precursor  ions  with  different  charge  states  have  different  ion
intensities, an average charge state can be calculated. Prediction of these charge states is
possible as the average charge state is generally influenced by the number of basic amino acid
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residues  in  the  peptide  sequence.  Computational  models  based  on  peptide  sequence  and
multivariate  linear  regression  demonstrate  the  ability  to  predict  the  peptide  charge  state  in
different datasets [103]. Other software, like Basophile, are based on analyzing the basicity of
the  N-  and  C-terminal  fragments  surrounding  a  peptide  bond  in  order  to  predict  proton
segregation [98].
5.6 Optimization based on prior knowledge
In the optimal design of a proteomics experiment theoretical and statistical considerations play a
fundamental role. On the other hand, in many scenarios an experimental design strategy can
also benefit from a prior analysis of existing knowledge regarding the process or proteome of
interest.  For  this  task the vast  amounts of  information deposited in  various  databases and
scattered in the literature can be explored, retrieved, filtered and analyzed with computational
tools in the course towards setting up an experiment [104]. In the next section we will provide
some hints towards which existing information can be relevant and how it could be utilized. In
many cases this task can be summarized as retrieving a set of proteins that are likely to be
observed with relevance to the given research question. This set can then be analyzed in silico
using a variety of computational tools to determine their physicochemical properties in order to
design a suitable experimental workflow. This allows reducing the "expected proteome" from the
full theoretical proteome to a much more likely and realistic proteome. It should however be
mentioned that this step comes at the risk of the so-called "bandwagon effect", if experimental
design parameters are (over-) optimized to reproduce earlier observations.
 
5.6.1 Using previously acquired experimental proteomics datasets
 
Any design of proteomics experiments should be preceded by an analysis of similar studies that
have previously been carried out  [105]. Obviously a literature survey is not only essential to
properly frame the research question in relation to the existing knowledge, but it is also essential
to explore the technical possibilities for the research question (unfortunately,  the literature is
more efficient in telling you what could work, than in revealing what may not work). However, the
low scalability and the dependence of expert interventions limits the systematic use of literature
information for proteomics experiment design. Below we will discuss resources that can help to
answer two important questions regarding the study that needs to be designed: 1) what do we
already  know;  and  2)  what  do  we  expect  to  observe.  Answers  to  these  questions  are
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indispensable to maximize the amount of relevant, trustworthy and new information from a new
experiment.
 
Organized data resources that can be relevant for systematical experiment design are the public
proteomics databases and repositories [106]. For shotgun proteomics the most important public
data  repositories  include,  among  others,  the  PRoteomics  IDEntifications  database  (PRIDE)
[107] and the Mass spectrometry Interactive Virtual Environment (MassIVE), both in the context
of the ProteomeXchange consortium [108], the Global Proteome Machine Database (GPMDB)
[109] ,  and  PeptideAtlas  [110].  These  databases  contain  experimental  spectra  and  protein
identifications for a vast range of model and other organisms. Additionally, for SRM data there is
the  PeptideAtlas  SRM  Experiment  Library  (PASSEL)  [111],  also  in  the  context  of  the
ProteomeXchange consortium. More specific, curated resources for the extraction of organism
and organelle- or biofluid-specific proteomes are for example the Human Proteinpedia  [112],
MAPU [113] and the Yeast Resource Center Public Data Repository [114]. For a comparative
review  of  the  major  data  repositories  and  their  features  we  refer  to  several  reviews
[115,116,106].
Another source of public data comes in the form of spectral libraries [117]. Spectral libraries are
generally used as an alternative approach to sequence database searching to identify fragment
spectra.  However,  because  spectral  libraries  explicitly  consist  of  representative  spectra  for
peptides  that  have  been  confidently  identified  in  past  experiments,  they  effectively  form  a
concise representation of the proteome. Furthermore, depending on the metadata retained in
the  spectral  libraries,  the  representative  spectra  can  be  linked  back  to  their  individual
experiments with their respective experimental set-up and conditions.
These resources can be of great value to perform a meta-analysis of the known status of a
given proteome and can answer the question which proteins can be expected to be observed
under given experimental circumstances or in a specific biological context. Their usefulness for
experimental design is largely dependent on the quality and accessibility of their experimental
metadata:  only  with  sufficient  and  well-organized  metadata  can  all  relevant  existing
experimental data efficiently be retrieved and interpreted from a repository. Alternatively, these
data sources are also at the basis of many machine learning based models  [86] that predict
various properties of a theoretical proteome. In this way they are indirectly used in many of the
predictive approaches covered earlier in this review.
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5.6.2 Using additional knowledge of the expected proteome
 
A second  level  in  which  prior  knowledge  can be  incorporated in  the  design  of  proteomics
experiments, is by using annotation databases. These databases collect experimentally proven
or otherwise inferred links between a given protein and specific terms that imply a function,
localization  or  other  property  of  the  protein.  Usually  the  terms  are  part  of  a  controlled
vocabulary,  i.e.  they  have  a  well-defined  meaning  that  is  curated  by  experts.  Annotation
databases  can  be  used  to  search  for  protein  entries  that  are  associated  with  a  specific
experimental context. In the context of experiment design, it could for example be relevant to
extract  all  proteins  that  are  linked  to  a  given biological  compartment  of  interest.  The most
obvious resource for  annotation  analysis  is  the Gene Ontology Consortium  [118] (GO),  but
pathway databases  such  as  KEGG  [119] and  reactome  [120] can  also  be  used  to  extract
functionally relevant proteomes for an in silico analysis prior to experiment design. A powerful
tool that provides systematic access to several of the aforementioned resources, and many
others, is BioMart  [121]. It  allows performing queries over many resources through a unified
interface,  both  in  interactive  (through  a  user-friendly  interface)  and  programmatic  ways.
Together these resources allow to extract identifiers of proteins that could be expected. These
identifiers can then be used to extract sequences and other features from resources such as
Uniprot (The UniProt Consortium, 2011) for subsequent analysis.
An important caveat is that although annotated genomes (and thus a set of coding sequences)
of  most  model  organisms  used  in  biomedical  research  are  available  in  public  databases,
identification of proteins from organisms with non-sequenced genomes still remains challenging.
Indeed,  as  protein  identification requires the matching of  tandem mass spectra of  (usually)
tryptic  peptides  to  genomes  held  in  (public)  databases,  unlocking  the  sequence  identity  of
organisms that  are  not  sequenced  yet  requires  a  different  approach.  Although  this  has  no
consequences  for  the  experimental  design  itself,  it  does  influence  the  data  processing.
Therefore, this should be firmly kept in mind, as computational optimization methods might not
take this into account directly.
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2. expert commentary 
Proteomics experiments are not that different from other high-throughput omics studies when it
comes to the statistical  design of  the  experiments.  Yet  the optimization  of  the  experiments
proper requires specific knowledge and expertise, which in turn impacts the study design. As a
result, the generalized statistical considerations that are applicable to any omics study need to
be interpreted in  the context  of  proteomics,  along with the concomitant  issues.  The choice
between a DDA, DIA or targeted proteomics approach for instance, is very fundamental to a
study, but is influenced much more directly by the strengths and weaknesses of these methods
than by the statistical  considerations that  each type of  analysis  requires.  Indeed,  it  can be
argued that proteomics study design is typically determined by the technological or biological
limitations  rather  than  by  the  statistics.  As  a  result,  it  is  very  important  for  proteomics
researchers to be aware of a wide variety of possible study designs, and to have access to
statisticians with sufficient proteomics-specific domain knowledge. 
Moreover, because of the enormous diversity in physico-chemical properties and abundances
that  are represented in  the proteome,  it  can be enormously beneficial  to  build  on previous
knowledge.  This  can  take  the  form  of  exploiting  previously  gleaned  optimal  experimental
conditions, either straight from the literature, or by comparing the properties of similar data sets
that have been deposited in the public domain. The most promising re-use of publicly available
proteomics data for this purpose however, lies in the successful abstraction of the knowledge in
predictive  models.  Such  models  are  particularly  interesting  because  these  can  learn  from
existing data to predict the properties and behavior of as-yet unseen analytes. As such, these
predictive models allow novel sample types, novel analytes, and novel study designs to be first
tested in silico. 
As an overall point of attention however, it was recently reported that very many studies in the
life sciences today perform very poorly when critically assessed for  bias  [122].  While not  a
problem of proteomics  per se, it is telling that the level of statistical rigor in the life sciences
leaves something to be desired. For the field of proteomics, which is after all an analytical field
in essence,  it  is  therefore important to focus much more intensely on designing adequately
powered,  well-considered  experiments.  However,  a  powerful  force  that  seems to  be  acting
against this increased level of rigor is the ability to publish findings across the impact factor
space regardless of correct design. Clearly, there is a role set aside for the community at large,
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to mandate more rigor, and to educate both authors and reviewers sufficiently to both design
good experiments, and to detect poorly designed ones.
3. 5 years perspective 
The proper design of proteomics experiments has increasingly become a focus point in the
community. This shift in focus from technology development to consolidation of the technique is
a signal of technology maturation. This same maturation is evident in the increased importance
of quality control and quality assurance, which are the analytical siblings of experimental design
[123,107]. Yet in order to successfully adopt more rigorous experimental practices, it is clear that
researchers in the field need to be better educated with respect to statistics.
Indeed, education really is the elephant in the room, and should therefore take center stage.
Researchers tend not to utilize suboptimal experimental designs out of malice, but rather out of
ignorance. It is highly illustrative that efforts to educate researchers at the postgraduate level,
such as review articles or dedicated tutorial-style articles (e.g., by the Nature Publishing Group;
http://www.nature.com/collections/qghhqm)  typically  cover  very  elementary  concepts.  This
indicates a fundamental lack of understanding that stems from the undergraduate training of
researchers in the life sciences. Nevertheless, most, if not all, curricula that lead to life sciences
degrees will implement one or more statistics courses, as well as analytics courses in which the
statistics should be applied. Yet despite the time and importance dedicated to these courses in
the vast majority of curricula, the tutorial examples cited above clearly demonstrate that the
practical working knowledge of researchers at the graduate level is lacking. Perhaps this is due
to the way in which statistics are taught, with a focus on the theory rather than the application,
and  certainly  with  too  limited  repetition  of  the  material  throughout  the  remainder  of  the
curriculum. Put in another way, how many students design their own experiments in their lab
work assignments?
This is perhaps the most  relevant  take-home message:  the education of  life scientists,  and
especially of those that will depend on complex, high-throughput analytics, should deliver on
three key points: (i) to instill into these students the importance of correct experimental design
from the very start; (ii) to provision the students with basic knowledge and fit-for-purpose tools to
allow the design of good experiments; and (iii) to hone this training into root skills by repeated
practice throughout their education.
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Correct experimental design is of crucial importance for the applicability and longevity of results
from  the  life  sciences.  The  field  of  proteomics,  as  one  of  the  high-throughput,  molecular
analytics disciplines, is directly confronted by this fundamental requirement. It is not however,
sufficient to acknowledge the importance of experimental design; we also need to ensure that
future proteomics researchers will be fully equipped to tackle this essential challenge. And for
this, we foremost need to consider how we train these researchers.
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